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ABSTRACT
HuD is a neuronal ELAV-like RNA-binding protein
(RBP) involved in nervous system development,
regeneration, and learning and memory. This
protein stabilizes mRNAs by binding to AU-rich
instability elements (AREs) in their 30 unstranslated
regions (30 UTR). To isolate its in vivo targets,
messenger ribonucleoprotein (mRNP) complexes
containing HuD were first immunoprecipitated
from brain extracts and directly bound mRNAs
identified by subsequent GST-HuD pull downs and
microarray assays. Using the 30 UTR sequences of
the most enriched targets and the known sequence
restrictions of the HuD ARE-binding site, we
discovered three novel recognition motifs. Motifs 2
and 3 are U-rich whereas motif 1 is C-rich. In vitro
binding assays indicated that HuD binds motif 3 with
the highest affinity, followed by motifs 2 and 1, with
less affinity. These motifs were found to be over-
represented in brain mRNAs that are upregulated
in HuD overexpressor mice, supporting the biologi-
cal function of these sequences. Gene ontology
analyses revealed that HuD targets are enriched in
signaling pathways involved in neuronal differen-
tiation and that many of these mRNAs encode
other RBPs, translation factors and actin-binding
proteins. These findings provide further insights
into the post-transcriptional mechanisms by which
HuD promotes neural development and synaptic
plasticity.
INTRODUCTION
mRNA stability is now recognized as a critical post-
transcriptional mechanism controlling the expression of
a large number of mammalian genes. Transcript stability
is dictated by cis-acting elements, mostly localized in the
30 untranslated region (30 UTR) and by the activity of
trans-acting factors, such as microRNAs (miRNAs)
and RNA-binding proteins (RBPs) (1–3). The best
characterized cis-acting instability-conferring sequence is
the AU-rich element [ARE; (4,5)]. These sequences were
originally described in short-lived transcripts encoding
cytokines, oncogenes, and growth factors, however,
mRNAs for proteins serving a wide variety of functions
have been recently identiﬁed as containing AREs (6).
AREs regulate mRNA decay by interacting with ARE-
binding proteins that either trigger mRNA decay [e.g.
KH homology splicing regulatory protein (KSRP),
tristetraprolin (TTP), AUF1 and butyrate response
factor 1 (BRF1)] or stabilization (e.g. Hu proteins) (1,2).
In addition to AREs, other elements regulating mRNA
stability have been described. For example, a GU-rich
element (GRE) that is a target of the CUG-binding
protein 1 (CUGBP1/EDEN-BP) was recently identiﬁed
in the 30 UTR of many unstable mRNAs (7–9).
Furthermore, a few reports have shown the presence of
instability sequences in the 50 UTR (10) and coding region
(11); yet, how common these non-30 UTR localizations are
is presently unclear.
Hu proteins are human homologs of Drosophila
embryonic lethal abnormal vision (ELAV, 12) and the
best-known mRNA stabilizing factors. There are four
mammalian ELAV-like/Hu proteins. While HuC and
HuD are exclusively expressed in neurons, HuB is found
in neurons and gonads, and HuR is ubiquitously
expressed in all tissues. Amongst the trans-acting factors
that mediate mRNA stabilization, HuD has been shown
to play a vital role in neural development and brain phys-
iology, as recently demonstrated by mouse lines either
lacking or over-expressing the protein (13–16). HuD
knock-out mice show neurogenesis deﬁcits as well as
abnormal motor control and development of cranial
nerves (13). Over-expression of HuD in transgenic mice
leads to alterations in hippocampal physiology and
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memory tasks (16,17). In addition to its role in the
central nervous system, HuD has also been associated
with axonal re-growth after peripheral nerve injury
(18,19). Overall, these studies demonstrate that HuD is
required for normal neural development, nerve regenera-
tion and synaptic plasticity (20,21).
At the molecular level HuD binds to several unstable
mRNAs and as a result of this interaction the target
transcripts are stabilized (22,23). HuD has three RNA-
recognition motifs (RRM) and we have previously
shown that the ﬁrst two RRMs of the HuD protein are
necessary for binding to GAP-43 mRNA, one of HuD’s
best characterized targets (22). However, these domains by
themselves are not suﬃcient to stabilize GAP-43 mRNA
in neuronal cells (24) as it also requires the interaction of
RRM III with long poly(A) tails (23). Besides GAP-43,
other mRNAs such as N-myc, AChE, tau, neuroserpin
and MARCKS mRNAs were shown to interact with
HuD in vitro and in vivo (2). However, the majority of
HuD’s targets in neurons remain to be elucidated.
Several recent studies identiﬁed mRNAs associated
with mRNPs containing diﬀerent RBPs using RNA
immunoprecipitation (RIP)-Chip assays, a procedure
known as ribonomics (25–28). As mRNPs may represent
eukaryotic post-transcriptional operons (29), this proce-
dure provides an important tool for deﬁning the biological
function of these RNA–protein complexes. HuD was
shown to bind other RBPs including the neuronal
ELAV-like protein HuB (30), TAP/NXF1, the primary
mRNA export receptor (31) and the IGF-2 mRNA-
binding protein IMP1a (32). Therefore, in order to deter-
mine which of the mRNAs in HuD-containing mRNPs
are directly interacting with this RBP, in the present
study we combined the original ribonomics protocol
with subsequent in vitro pull down assays with GST-
HuD. Using this two-step isolation method, nearly 700
new HuD targets were identiﬁed. The 30 UTRs of these
targets were then used to discover new HuD-binding
motifs and identify the biological and molecular
pathways regulated by this protein. As a group, HuD
target mRNAs encoded proteins involved in several sig-
naling pathways required for neural diﬀerentiation and
synaptic remodeling. Interestingly, many of the proteins
encoded are also RBPs and translation factors, suggesting
that HuD is part of a complex post-transcriptional gene
regulatory network.
MATERIALS AND METHODS
mRNA immunoprecipitation
mRNPs containing HuD were immunoprecipitated using
the ribonomics protocol described by Tenenbaum and
colleagues (25,26). Brieﬂy, forebrain tissue from the
HuD transgenic mice (16) were homogenized using a
Dounce homogenizer in Polysome Lysis Buﬀer (100mM
KCl, 5mM MgCl2, 10mM HEPES pH 7.0, 0.5%
Nonidet P-40, 1mM dithiothreitol, 100U/ml RNAsin,
0.2% vanadyl ribonucleoside complexes, leupeptin and
aprotinin). Lysates were cleared by centrifugation at
14000 g for 10min at 4 C and frozen at  80 C until
use. Protein G-Sepharose beads (Sigma, St. Louis, MO)
were coated with anti myc-monoclonal antibody (9B11
mouse mAb, Cell Signaling Technology, Danvers, MA)
or non-immune mouse IgG (Sigma, St. Louis, MO)
under constant rocking in NT2 buﬀer [50mM Tris (pH
7.4), 150mM NaCl, 1mM MgCl2 and 0.05% Nonidet
P-40] supplemented with 5% BSA. Brain extracts
(100ml) were immunoprecipitated with 50ml of coated
beads in 850ml of NT2 buﬀer supplemented with 8 units
of RNAsin, 1mM vanadyl ribonucleoside complexes,
1mM DTT and 15mM EDTA for 2h at room tempera-
ture under constant rocking. After beads were washed six
times with ice-cold NT2 buﬀer, proteins were digested
with proteinase K and mRNAs puriﬁed by phenol–
chloroform extraction and ethanol precipitation.
GST HuD pull down assays
Recombinant GST-HuD protein was prepared from BL21
Escherichia coli transformed with pGEX-2T-HuD plasmid
as described previously (23,33). Brieﬂy, BL21 cells were
induced with IPTG and lysed by sonication in Fast
Break Cell Lysis Reagent (Promega, Madison, WI)
supplemented with Halt Protease inhibitor (Pierce,
Rockford, IL) and RQ1 DNase (Promega, Madison,
WI). After centrifugation for 15min at 4 Ca t
27000 g, the supernatant was incubated for 1h at 4 C
with MagneGST Glutathione Particles (Promega,
Madison, WI). Beads were washed with Binding/Wash
buﬀer (Promega, Madison, WI) and incubated with
600ng of ampliﬁed RNA from the previous ribonomics
step for 30min at 4 C in binding buﬀer (10mM HEPES,
3mM MgCl2, 40mM KCl, 1mM DTT, 400U of RNase
out and 5% glycerol). After incubation and washes with
binding buﬀer without glycerol, RNA was extracted as
described above.
mRNA ampliﬁcation and array hybridization
Total RNA (10ng) from the ﬁrst and second puriﬁcation
steps was converted to double-stranded cDNA using the
GeneChip Expression 30-Ampliﬁcation Two-Cycle
Target Labeling and Control Reagents Kit (Aﬀymetrix,
Santa Clara, CA) according to manufacturer’s protocols.
The resulting cDNA was used for the in vitro synthesis of
biotin-labeled cRNA using the GeneChip IVT Labeling
Kit (Aﬀymetrix). cRNA was cleaned using the GeneChip
Sample Cleanup Module and fragmented into 35–200
base pair fragments using a magnesium acetate buﬀer
(Aﬀymetrix). In total, 6.5mg of labeled cRNA was
hybridized to Aﬀymetrix GeneChip Mouse Genome
430 2.0 for 16h at 45 C. The arrays were washed and
stained according to the manufacturer’s recommendations
using the GeneChip Fluidics Station 450 (Aﬀymetrix).
Each array was scanned using the GeneChip Scanner
3000 (Aﬀymetrix) and globally scaled to 150 using the
Aﬀymetrix GeneChip Operating Software (GCOS v1.4).
Microarray analysis
Samples were run in triplicates. For target identiﬁcation,
raw data ﬁles from the Aﬀymetrix arrays were normalized
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normalized values were used to calculate the enrichment
ratios of HuD IP versus IgG IP and GST-HuD versus
GST pull downs. Probes with absent calls in at least two
out of three replicates in the HuD IP and the GST-HuD
pull down chips but not in the controls (IgG IP and GST
pull down) were excluded from the analysis and the
average enrichment for each probe was used for statistical
analyses. A similar analysis was used to identify mRNAs
that were up-regulated in the brains of HuD transgenic
overexpressor mice (HuD-Tg). Brieﬂy, mRNAs from
three HuD-Tg mice and three control (non-transgenic)
littermates were analyzed by Aﬀymetrix 430 2.0 chips
and mRNAs that had ‘present’ calls and were signiﬁcantly
upregulated (P<0.05), as determined using GeneSpring
9.0 (Agilent Technologies, Santa Clara, CA), were used
for HuD motif analyses. In addition, we generated a list
of all the mRNA expressed in mouse forebrain using
transcripts from control forebrains with ‘present’ calls
and raw expression values more than 100, which
corresponds to twice the background level. This set,
which consisted of 17010 transcripts corresponding to
9757 genes, was used as reference for HuD target
analyses (see below).
Sequence analysis
The 30 UTR, coding region (CR) and 50 UTR sequences of
HuD targets, the genes in the Aﬀymetrix 430 2.0 chip, the
mouse forebrain set described above and all the genes
available in the Ensembl database were downloaded
from Ensembl BioMart, release 49, Mus musculus genes
NCBIM37 (http://www.ensembl.org/biomart/index.html).
The datasets were made non-redundant based on gene ID
using our own Perl scripts. If more than one sequence was
available for a gene, the longest was chosen for further
analysis. 30 UTR nucleotide composition and length,
presence of each ARE subtype, and U stretches were
analyzed using custom scripts written in Perl v5.8.8
and BioPerl 1.5.2 modules (http://www.bioperl.org),
which are available upon request. Diﬀerences between
datasets were analyzed by two by two contingency tables
with Chi-square test using the R statistical package
version 2.7.1.
Motif search and analysis
Bioinformatics analyses for HuD-binding motifs consid-
ered both the 30 UTR sequences of the 72 most enriched
targets and the restrictions imposed by the three-
dimensional structure of the complex between the ﬁrst
two RRMs in HuD and two diﬀerent Class I and II
AREs (34). The 30 UTR sequences of the 72 most
enriched HuD targets downloaded from Ensembl
BioMart and 25 nucleotide (nt) long fragments containing
the consensus binding sequence YUNNYUY in the
middle were extracted. Since the YUNNYUY sequence
is not very restrictive, One-thousand seven-hundred
thirty-ﬁve fragments were obtained. These sequences
were used as a training set for motif search using
MEME software [http://meme.sdsc.edu/meme; (35,36)].
A diagram of the implemented motif search strategy
is shown in Figure 3A. Probability matrices of the
new HuD-binding motifs were represented graphically
using WebLogo [http://weblogo.berkeley.edu/; (37)]. For
analyzing the frequency of each new HuD-binding motif
in the diﬀerent datasets and the location of each motif,
we used a Perl script that searches for the following
regular expressions (allowing one mismatch): [CG][CT]
[CT]TC[CT][CT]TC[TC]C[TC]C, [TG]TTTGTTT[TG]
[GT]TTT, and TTTTTTTTT[TA]AAA, for motifs 1, 2
and 3, respectively. Diﬀerences between datasets were
analyzed by two by two contingency tables with Chi-
square test using the R statistical package version 2.7.1.
Nitrocellulose ﬁlter binding assay
Ribo-oligoribonucleotides (Integrated DNA Techno-
logies, Coralville, IA) were end-labeled with P
32gamma-
ATP from MP Biomedicals using polynucleotide kinase
(New England Biolabs). Labeled oligoribonucleotides
were puriﬁed using mini Quick Spin Columns (Roche
Applied Sciences, Indianapolis, IN) and used immediately
for in vitro binding assays. Reaction mixtures (20ml)
contained 50mM Tris (pH 7.0), 150mM NaCl, 0.25mg/
ml bovine serum albumin, 0.25mg/ml tRNA and labeled
oligoribonucleotides as indicated. We used 100ng per
reaction of recombinant HuD for motifs 2 and 3, and
600ng for motif 1. After 20min incubation at 37 C, the
mixtures were diluted 1:6 with wash buﬀer (20mM Tris–
HCl pH 7.0 and 50mg/ml tRNA) and ﬁltered through a
nitrocellulose membrane using a dot blot apparatus.
Membranes were washed twice with wash buﬀer. To deter-
mine the non-speciﬁc binding, similar reactions were
carried out in parallel with a 100 molar excess of unlabeled
oligoribonucleotide. Bound radioactivity was determined
using a phosphor-imager (Personal Molecular Imager,
BioRad). Serial dilutions of each labeled oligonucleotide
were blotted directly onto the membrane and used to
measure total radioactivity.
Gene ontology analysis
The Gene Ontology Tree Machine [GOTM, http://
bioinfo.vanderbilt.edu/gotm/, (38)] and WebGestalt
[http://bioinfo.vanderbilt.edu/webgestalt, (39)] programs
were used for these studies. The frequencies and
numbers of HuD targets in each gene ontology category
were calculated and compared to those in the mouse
genome. A hypergeometric distribution test was used to
calculate the statistical signiﬁcance of the observed (HuD
targets dataset) over the predicted (genomic) frequency.
P-values smaller than 0.01 were considered statistically
signiﬁcant and only gene ontology categories with
more than three genes in the HuD targets dataset were
considered. Biological pathways associated with HuD
targets were identiﬁed using the links to the Kyoto
Encyclopedia of Genes and Genomes (KEGG) available
thorough GOTM and WebGestalt. MetaCore pathway
analysis software was also used (GeneGO, Encinitas, CA).
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Identiﬁcation of HuD targets
HuD expression is critical for normal brain development
and maturation and thus the identiﬁcation of the reper-
toire of HuD’s targets is an important ﬁrst step towards
the characterization of the molecular processes regulated
by this RBP. In this study, we used two consecutive puri-
ﬁcation steps to isolate HuD-bound mRNAs (Figure 1).
First, neuronal HuD-containing mRNPs were puriﬁed
from brain extracts of HuD overexpressor mice (14) by
immunoprecipitation (IP). Since none of the commercially
available HuD antibodies worked well for the IP step,
antibodies against the myc-tag present in the HuD
transgene were used instead to pull down the protein.
Validating the IP step we found that GAP-43 and
neuroserpin mRNAs, two of the known targets of HuD,
were enriched close to 7- and 70-fold, respectively, in the
HuD IP (Supplementary Figure S1). Following mRNA
extraction and oligo-dT-T7 directed linear ampliﬁcation
direct targets were subsequently enriched by aﬃnity puri-
ﬁcation using GST-HuD protein (Figure 1). After each
step of puriﬁcation, mRNAs were isolated, subjected to
a two-round linear ampliﬁcation and hybridized to
Aﬀymetrix 430 2.0 arrays.
Enrichments were calculated by dividing the signal of
each probe set in the HuD IP or GST-HuD pull down by
the signal of the same probe in the non-immune IgG IP or
control GST pull down, respectively. The mean enrich-
ment of mRNAs in the IP step was 2-fold and the use of
the GST-HuD step increased this value to 12-fold. As
indicated above, one possible explanation for this
ﬁnding is that many of the mRNAs immunoprecipitated
in the ﬁrst step may be interacting with other proteins
in the mRNP. Also, since this is the ﬁrst time that the
RIP-Chip protocol was used for the analyses of Hu
protein targets in the brain and Aﬀymetrix arrays were
probed with equal amounts of control and HuD IP
RNA, the global enrichment in the IP step was lower
than that observed for other Hu proteins in cultured
cells (25,40). Nevertheless, analyses of the mRNAs
enriched in the brain HuD-IP step with those associated
with HuR in Jurkat cells (40) resulted in similar enrich-
ment plots for both sets of mRNAs (data not shown).
Overall, we found that 5412 probes corresponding to
3529 known genes and expressed sequence tags (ESTs)
showed more than 2-fold enrichment after the ﬁrst step
and 1189 probes (1034 genes) had z-scores above 1.5
after the two consecutive isolation steps. Seven hundred
probes (673 genes) met both enrichment criteria and were
operationally deﬁned as putative HuD targets. Table 1
shows the 70 most enriched mRNAs in the dataset and
the complete list of 700 probes is shown in Supplementary
Table S1. Although not all the previously reported targets
of HuD were included in this dataset, we found that all of
them were enriched at least 3-fold after the second puriﬁ-
cation step and/or contained one of the three RNA-
binding motifs described below (Figure 3, Table 3).
30 UTR sequence characteristics of HuD targets
The 50 UTR, coding region (CR), and 30 UTR sequences
of all the mRNAs in the HuD target set, mouse genome,
and Aﬀymetrix 430 2.0 chip were extracted from Ensembl
BioMart. Since  50% of the genome is expressed in the
brain, we generated a set of forebrain-expressed mRNAs
(see ‘Materials and Methods’ section) and used this set of
transcripts to compare with HuD targets as well. As
shown in Table 2, the average 30 UTR length in HuD
target mRNAs is surprisingly longer than in then
genome, the Aﬀymetrix chip and the forebrain set (HuD
targets: 1909nt versus 1121 in mouse genome, 1142 in the
chip and 1325 in forebrain transcripts). Also, we found
that the forebrain set had slightly longer 30 UTRs and
slightly shorter 50 UTRs than the genome and chip sets.
The increased 30 UTR length of forebrain mRNAs relative
to the entire mouse transcriptome is consistent with a
previous report showing a positive correlation between
the 30 UTR length of mRNAs and their brain-speciﬁc
expression (41) and with the observations that some
brain-expressed mRNAs have longer 30 UTRs than their
counterparts in other tissues (42–44). Regarding the
relative abundance of all four nucleotides in the
sequence, we found that the 30 UTRs in the HuD target
dataset are slightly more U-rich than the three reference
datasets. No diﬀerence between the Mus musculus genome
and the genes present in the Aﬀymetrix chip were
observed, demonstrating that the Aﬀymetrix 430 2.0
chip contains an unbiased representation of all mouse
genes. Furthermore, aside for small diﬀerences in the
lengths of the 50 and 30 UTRs, the properties of forebrain
transcripts did not diﬀer signiﬁcantly from those of the
other two reference datasets (Table 2, Figure 2).
Subsequent analyses examined the frequency of known
mRNA instability elements in the 30 UTRs of mRNAs in
three reference transcripts sets and the HuD target
A Purification of
HuD mRNP
Brain S100 extracts
from HuD Tg mice
Myc-HuD pull down
RNA isolation
Oligo-dT-T7 amplification
Affymetrix 430 2.0 array
Amplified mRNAs
from HuD mRNP
Pull down with
recombinant GST-HuD
RNA isolation
Oligo-dT-T7 amplification
Affymetrix 430 2.0 array
Purification of
direct HuD targets
Figure 1. Identiﬁcation of HuD target mRNAs. Experimental strategy
implemented for analyzing HuD target mRNAs at genomic scale. The
ﬂow chart shows the two sequential steps used for the identiﬁcation of
HuD targets.
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Probe set ID Fold
enrichment
Gene
symbol
Description Ensembl
1438554_x_at 19.43 Eif4h Eukaryotic translation initiation factor 4H ENSMUSG00000040731
1452833_at 19.42 Rapgef2 Rap guanine nucleotide exchange factor (GEF) 2 ENSMUSG00000062232
1424358_at 19.16 Ube2e2 Ubiquitin-conjugating enzyme E2E 2 (UBC4/5 homolog, yeast) ENSMUSG00000058317
1434277_a_at 19.08 Ypel2 Yippee-like 2 (Drosophila) ENSMUSG00000018427
1416313_at 18.85 Mllt11 Myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog,
Drosophila); translocated to, 11
ENSMUSG00000053192
1434310_at 18.78 Bmpr2 Bone morphogenic protein receptor, type II (serine/threonine kinase) –
1429839_a_at 18.63 Yaf2 YY1 associated factor 2 ENSMUSG00000022634
1435521_at 18.5 Msi2 Musashi homolog 2 (Drosophila) ENSMUSG00000069769
1457248_x_at 18.47 Hsd17b7 Hydroxysteroid (17-beta) dehydrogenase 7 ENSMUSG00000026675
1435807_at 18.46 Cdc42 Cell division cycle 42 homolog (S. cerevisiae) ENSMUSG00000006699
1416767_a_at 18.45 RIKEN cDNA 1110003E01 gene ENSMUSG00000037822
1433519_at 18.43 Nucks1 Nuclear casein kinase and cyclin-dependent kinase substrate 1 –
1450021_at 18.38 Ubqln2 Ubiquilin 2 ENSMUSG00000050148
1437457_a_at 18.38 Mtpn Myotrophin ENSMUSG00000029840
1416082_at 18.32 Rab1 RAB1, member RAS oncogene family ENSMUSG00000020149
1448100_at 18.31 RIKEN cDNA 4833439L19 gene ENSMUSG00000025871
1447776_x_at 18.29 Rab6 RAB6, member RAS oncogene family ENSMUSG00000030704
1432198_at 18.29 RIKEN cDNA A230083H22 gene ENSMUSG00000039126
1448504_a_at 18.28 Cbx3 Chromobox homolog 3 (Drosophila HP1 gamma) ENSMUSG00000029836
ENSMUSG00000059647
1415971_at 18.23 Marcks Myristoylated alanine rich protein kinase C substrate ENSMUSG00000069662
1426776_at 18.21 Wasl Wiskott–Aldrich syndrome-like (human) ENSMUSG00000029684
1433540_x_at 18.16 Ppp1cb Protein phosphatase 1, catalytic subunit, beta isoform ENSMUSG00000014956
1426401_at 18.15 Ppp3ca Protein phosphatase 3, catalytic subunit, alpha isoform ENSMUSG00000028161
1419112_at 18.12 Nlk Nemo like kinase ENSMUSG00000017376
1423895_a_at 18.11 Cugbp2 CUG triplet repeat, RNA-binding protein 2 ENSMUSG00000002107
1423220_at 18.07 Eif4e Eukaryotic translation initiation factor 4E ENSMUSG00000028156
1458351_s_at 18.06 Klhl2 Kelch-like 2, Mayven (Drosophila) ENSMUSG00000031605
1440270_at 18.05 Fgf12 Fibroblast growth factor 12 ENSMUSG00000022523
1434082_at 18.04 Pctk2 Serine/threonine-protein kinase PCTAIRE-2 ENSMUSG00000020015
1434232_a_at 18.04 RIKEN cDNA 2610030H06 gene ENSMUSG00000073131
1428473_at 18.03 Ppp3cb Protein phosphatase 3, catalytic subunit, beta isoform ENSMUSG00000021816
1448184_at 18.03 Fkbp1a FK506-binding protein 1a ENSMUSG00000032966
1447669_s_at 18.02 Gng4 Guanine nucleotide binding protein (G protein), gamma 4 subunit ENSMUSG00000021303
1428970_at 18.01 Nat13 N-acetyltransferase 13 ENSMUSG00000022698
1437585_x_at 17.99 Zfp161 Zinc ﬁnger protein 161 ENSMUSG00000049672
1419246_s_at 17.99 Rab14 RAB14, member RAS oncogene family ENSMUSG00000026878
1438007_at 17.94 Expressed sequence AI851790 ENSMUSG00000044071
1424852_at 17.87 Mef2c Myocyte enhancer factor 2C –
1436452_x_at 17.82 Tmed2 Transmembrane emp24 domain traﬃcking protein 2 ENSMUSG00000029390
ENSMUSG00000074460
1428416_at 17.79 RIKEN cDNA 3110050N22 gene ENSMUSG00000043542
1417377_at 17.78 Cadm1 Cell adhesion molecule 1 ENSMUSG00000032076
1433521_at 17.75 Ankrd13c Ankyrin repeat domain 13c ENSMUSG00000039988
1433751_at 17.73 Slc39a10 Solute carrier family 39 (zinc transporter), member 10 ENSMUSG00000025986
1424215_at 17.72 Fundc1 FUN14 domain containing 1 ENSMUSG00000025040
1434620_s_at 17.72 RIKEN cDNA 2610024E20 gene ENSMUSG00000036501
1421323_a_at 17.71 G3bp2 GTPase activating protein (SH3 domain) binding protein 2 ENSMUSG00000029405
1423309_at 17.7 Tgoln1 Trans-golgi network protein ENSMUSG00000056429
1426864_a_at 17.7 Ncam1 Neural cell adhesion molecule 1 ENSMUSG00000039542
1424683_at 17.67 RIKEN cDNA 1810015C04 gene ENSMUSG00000022270
1418067_at 17.65 Cﬂ2 Coﬁlin 2, muscle ENSMUSG00000062929
1437801_at 17.62 Morf4l1 Mortality factor 4 like 1 ENSMUSG00000062270
1428537_at 17.62 Csnk1a1 Casein kinase 1, alpha 1 ENSMUSG00000024576
1419971_s_at 17.61 Slc35a5 Solute carrier family 35, member A5 ENSMUSG00000022664
1417410_s_at 17.61 Prkci Protein kinase C, iota ENSMUSG00000037643
1417411_at 17.61 Nap1l5 Nucleosome assembly protein 1-like 5 ENSMUSG00000029804
1418436_at 17.6 Stx7 Syntaxin 7 ENSMUSG00000019998
1422748_at 17.58 Zeb2 Zinc ﬁnger E-box binding homeobox 2 ENSMUSG00000026872
1434820_s_at 17.57 Pkig Protein kinase inhibitor, gamma ENSMUSG00000035268
1415911_at 17.57 Impact Imprinted and ancient ENSMUSG00000024423
1454976_at 17.55 Sod2 Superoxide dismutase 2, mitochondrial ENSMUSG00000006818
1433986_at 17.52 cDNA sequence BC024659 –
1437016_x_at 17.46 Rap2c RAP2C, member of RAS oncogene family ENSMUSG00000050029
1434106_at 17.46 Epm2aip1 EPM2A (laforin) interacting protein 1 ENSMUSG00000046785
1416008_at 17.45 Satb1 Special AT-rich sequence binding protein 1 ENSMUSG00000023927
(continued)
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contained signiﬁcantly higher frequencies of these motifs.
Because some of the motifs were very rare, to easily visu-
alize diﬀerences the data were normalized to the frequency
in the genome (Figure 2A, inset). Of the known instability-
conferring sequences, the ARED motif, deﬁned by the
following regular expression [AU][AU][AU]U(AUUUA)
UUU[AU] with 1 mismatch allowed in the pentamer
ﬂanking regions (6) showed an approximate 2-fold enrich-
ment in the HuD target dataset. However, this motif was
present in only 20% of the targets. We then examined the
presence of the AUUUA pentamer and found a modest
but statistically signiﬁcant increase in the frequency of this
sequence in the HuD target dataset. However, given that
this motif is present at a high frequency in the genome
( 60% of the genes) and a single AUUUA motif by
Table 1. Continued
Probe set ID Fold
enrichment
Gene
symbol
Description Ensembl
1456177_x_at 17.44 Zfp706 Zinc ﬁnger protein 706 ENSMUSG00000062397
1416501_at 17.44 Pdpk1 3-phosphoinositide dependent protein kinase-1 ENSMUSG00000024122
1423684_at 17.44 Hnrpk Heterogeneous nuclear ribonucleoprotein K ENSMUSG00000021546
1426924_at 17.4 Rc3h2 Ring ﬁnger and CCCH-type zinc ﬁnger domains 2 ENSMUSG00000075376
1437288_at 17.38 Impad1 Inositol monophosphatase domain containing 1 ENSMUSG00000066324
1429579_at 17.37 RIKEN cDNA 6330407I18 gene –
The top 70 most enriched mRNAs of the 700 putative HuD targets. The complete dataset is shown in Supplementary Table S1.
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Figure 2. ARE frequency and U content in HuD target genes. (A) The presence of the diﬀerent AREs was analyzed in 30 UTR sequences of the
entire mouse genome (white bars), the genes present in the Aﬀymetrix 430 2.0 chip (light gray bars), a set of forebrain expressed transcripts (dark
gray bars) and in the HuD target dataset (black bars). Inset shows the same data normalized to the frequency in the genome. (B) Analysis of the
percentage of Us in 20nt long stretches in the 30 UTRs of the mouse genome, Aﬀymetrix 430 2.0 chip, and HuD targets. Inset shows the diﬀerence
between HuD targets and mouse genome. (C) Percentage of genes with segments of 70% Us as a function of stretch length. Inset shows the diﬀerence
between HuD targets and mouse genome. (D) Frequency of genes with 20nt long fragments in the 30 UTR containing at least 70% Us in all the
datasets described in panel A. ***P<0.0001 after a Chi-square test.
122 Nucleic Acids Research, 2010,Vol. 38,No. 1itself does not constitute an ARE, this sequence is an
unlikely candidate for a HuD-recognition motif. The
search for ARE motifs was then restricted to overlapping
AUUUAs [(AUUUA)n] or AUUUA motifs embedded in
a U-rich region (Type I ARE) deﬁned arbitrarily as a 20nt
long stretch with at least 60% U. Overlapping AUUUA
pentamers were present at high levels in the HuD target
dataset relative to the three reference datasets, but they
only accounted for  10% of the HuD targets. In
contrast, type I AREs were not enriched in this set.
Analysis of the type II ARE sub-categories proposed by
Wilusz and colleagues (1) revealed that that most of these
sub-categories were barely represented in the genome.
However, sub-categories IID and IIE were more
frequent in the HuD target 30 UTRs. Finally, we
searched for the recently reported G-rich element [GRE;
(9)] and found that the frequency of GREs was increased
among HuD targets. Taking together all the known insta-
bility motifs, only 42.48% of all HuD targets could be
explained by these sequences suggesting that other
elements are involved in HuD target recognition.
The common feature of the previously analyzed ARE
sequences is a high U content. Therefore, we performed a
detailed analysis of the U content in the 30 UTR of HuD
targets. Figure 2B shows the frequency of 20nt long
stretches with diﬀerent percentages of U. As the percent-
age of U increases, the fraction of genes containing these
sequences diminishes, however, the HuD target dataset
shows a higher number of mRNAs with high U content.
When the diﬀerence between percentage of genes in the
HuD targets and the Mus musculus genome was plotted
versus percentage of U (Figure 2B, inset), the curve
showed a peak at 70% U, suggesting that this percentage
is needed for HuD binding. Figure 2C presents a similar
analysis, but with a ﬁxed percentage of U set at 70 and
variation in the length of the window. The results show an
expected decrease in the percentage of genes meeting the
criteria as the window gets longer, with the maximum dis-
crimination between HuD targets and the mouse genome
at a window length of 20nts (Figure 2C, inset). Analysis of
the frequencies of mRNAs having 20nt long stretches with
70% U in the 30 UTR (Figure 2D) revealed that 80% of
the HuD targets have this characteristic, a value that was
highly signiﬁcant when compared to the genome, chip and
forebrain datasets.
Discovery of new HuD-binding motifs
Because ARE and GRE sequences only explained a
fraction of the motifs present in HuD targets and the
20nt and 70%U criteria is not sequence-speciﬁc, subse-
quent studies searched for new HuD-binding motifs. As
shown in Figure 3A, the 30 UTR sequences of the 72 most
enriched HuD targets were used to extract 25nt long
fragments containing the sequence YUNNYUY in the
middle. This sequence reﬂects the minimal binding motif
that was derived from modeling studies of the crystal
structure of the complex of RRMs I and II in HuD with
class I and II AREs (34). Using this ﬁlter to remove phys-
iologically irrelevant sequences 1735 fragments were
obtained, and this new dataset was used as a training set
to search for new HuD-binding motifs. Using a multiple
expectation maximization algorithm implemented in the
MEME software (35,36), we found three motifs with sta-
tistically signiﬁcant E-values, which are represented in
Figure 3B by WebLogo graphics (37). Supplementary
Table 2 shows the probability matrix for each individual
motif. The ﬁrst motif is pyrimidine-rich with a preponder-
ance of C and a lower U content. This motif is analogous
to a C-rich instability element that is present in a-globin
and other mRNAs and that is recognized by the poly(C)-
binding protein (45,46). The second motif is U-rich with
some interspersed Gs, and very similar to the GRE motif
(9) and the binding motif of sex-lethal, another homolog
of Hu proteins in Drosophila melanogaster (47). The last
motif is also U-rich with several As and thus is compara-
ble to the classical type I and II AREs.
If these motifs are indeed recognized by HuD, mRNAs
carrying these motifs should be present at higher fre-
quency in the HuD target dataset than in the three refer-
ence datasets (mouse genome, Aﬀymetrix chip and
forebrain transcripts). As shown in Figure 3D the fre-
quency of motif 1 is increased in the 50 UTR and the 30
UTR of HuD targets but not in the coding region. Motifs
2 and 3 showed a very similar pattern with highly signif-
icant increases in the 30 UTR and a slight increase in the 50
UTR and coding regions (Figures 3E and F). Analysis of
the distribution of the three motifs (Figure 3C) showed
that  80% (456 out of 572) of the target mRNAs have
at least one of the motifs,  10% have all three motifs
in their 30 UTR and 33% have two motifs. Subsequent
analyses mapped the localization of the three motifs in a
set of known and novel HuD targets. As shown in Table 3,
with the exception of tau, one of the mRNAs identiﬁed as
a target of HuD in a previous study (32), all the known
HuD targets contain at least one of the motifs. Some of
the targets such as Musashi 2, N-CAM1, Neuroserpin and
CaMkinIIa mRNAs have a large number of motifs while
others such as Homer 1, Fkbp1a, PPP1cb and PPP3ca
have only one motif per 30 UTR. In addition, one of the
known targets of HuD, the p27 mRNA, contains HuD-
binding motifs both in the 50 and 30 UTRs, consistent with
a role of HuD in translation of this mRNA (48).
Altogether these results indicate that the majority of
HuD targets can be explained by the presence of these
new motifs.
Aﬃnity of HuD for the three motifs
To directly test whether HuD binds these new motifs and
to determine the binding aﬃnities we performed in vitro
binding assays using recombinant protein and synthetic
radiolabeled ribo-oligonucleotides corresponding to the
most likely sequence of each of the three motifs. The
speciﬁc binding of HuD to each motif was calculated by
subtracting non-speciﬁc binding, which was assessed by
the addition of 100 times molar excess of unlabeled ribo-
oligoribonucleotide. The aﬃnities of recombinant HuD
for each motif were then calculated using non-linear
regression analyses. As shown in Figure 4, HuD interacts
with diﬀerent aﬃnities with each of the three sequences,
with motif 3 showing the highest aﬃnity followed by motif
Nucleic AcidsResearch, 2010, Vol.38,No. 1 1232 and the C-rich motif 1 showing the least aﬃnity
(Kd=2.9nM motif 3, 6.9nM motif 2 and 27.3nM motif
1). Taken together, these data provides experimental val-
idation of the in silico identiﬁed HuD-binding motifs.
Enrichment of HuD-binding motifs in genes upregulated
in HuD-Tg mice
To further validate the biological signiﬁcance of the three
binding motifs we determined the frequency of each
sequence in a dataset of genes upregulated in the brains
of HuD overexpressor mice (HuD-Tg). As described
previously, HuD-Tg mice have increased levels of HuD
in neurons of the forebrain (14) and increased levels of
GAP-43 and AChE mRNAs, two well characterized
HuD targets (14,19). Microarray gene expression
analysis of the HuD-Tg mice forebrain identiﬁed 646
probe sets representing 419 transcripts that had a
‘present’ call and whose expression was signiﬁcantly
upregulated in these mice (P<0.05, t-test). Sequence
analyses of this set of mRNAs revealed that the frequency
of the three motifs (motif 1, 36.3%; motif 2, 36.3% and
motif 3, 21.2%) was signiﬁcantly increased in their 30
UTRs (Figure 5). Also, we found that the 50 UTRs of
upregulated mRNAs had increased frequencies of motif
1 but decreased frequencies of motifs 2 and 3. Finally,
our ﬁnding that many upregulated transcripts did not
contain HuD-binding motifs suggest that some of the
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Figure 3. Identiﬁcation of the HuD-binding motifs. (A) Experimental strategy implemented to identify HuD-binding motifs. (B) WebLogo
representations of the three identiﬁed HuD-binding sequences. (C) Venn diagram showing the distribution of the three new HuD-binding motifs
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D. (F) Same analysis for motif 3. ***P<0.0001 of HuD targets versus each of the three reference datasets. (a) P<0.05 HuD targets versus genome
and forebrain, (b) P<0.05 versus genome, P<0.01 versus chip and P<0.0001 versus forebrain, (c) P<0.05 versus chip and versus forebrain and
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124 Nucleic Acids Research, 2010,Vol. 38,No. 1observed gene expression changes are indirect events
regulated by HuD targets rather that direct HuD eﬀects,
which is expected in animals with constitutive HuD
overexpression.
Gene ontology analysis of HuD targets
It has been proposed that mRNAs coordinately regulated
by the same RBP comprise a post-transcriptional operon
or ‘RNA regulon’ (49). To gain a further understanding
of the biological processes regulated by HuD, subsequent
studies examined the Gene Ontology distribution of
HuD targets (Figure 6). Several gene ontology categories
were signiﬁcantly enriched in HuD targets relative to the
genome. Amongst these categories were axon guidance
and regulation of neuron diﬀerentiation, two processes
that are known to be regulated by HuD in several
models. Other biological processes that were targeted by
Table 3. Predicted location of HuD-binding motifs in selected known and new HuD targets
mRNA Motif 1 Motif 2 Motif 3
Known HuD targets
GAP-43 128 332 – –
MARCKS 518 522 526 530 534 538 542 546 151 158 275 276 277 278 279 111 559 560
Neuroserpin 1801 1803 1805 1807 1809 1811
1813 1815 1817 1819 1821 1823
1825 1827 1829 1831 1833 1835
1837 1839 1841 1843
2073 615
N-myc – – 244 245 369
p21 waf1 133 1211 – –
tau – – –
VEGF 939 1261 – 397
p27 5UTR 225 233 306 436 –
p27 3UTR – 878 879 880 881 882 883 884
885 886 887 888 889
475 597 891
New HuD targets
eIF4e – 563 657 –
HuR – 1190 1199 –
HuB – 456 –
Fkbp1a 976 – –
PPP1cb 985 – –
PPP3ca – 15 –
CaMkinIIa 1475 1483 1485 1487 1491 1497 1512
3032 3034 3036 3038 3040 3042
3044 3046 3048 3050 3052 3054 3056
3058 3060 3062 3064 3066 3068 3070
3294 3298 3302 3306 3312 –
Homer1 – – 754
Rab1 891 1247 1249 – –
N-CAM1 75 77 79 81 83 744 1108 1109 1317 1334 1351 1352
1353 1354 1355 1356 1357 1358 1359
2833 2837
2705
Musashi 2 274 276 280 253 416 421 422 426 456 461 1558 1563
1570 1575 1764 1765 2258 2263 2760
3632 3638 3889 4248 4253
1141 1580 1767 1768 1871 1872
2955 2956 3642 4082 4083
The predicted location of each motif in the 30 UTR of selected HuD targets. As described in the ‘Materials and Methods’ section, Pearl scripts were
used to search for the location of each motif, allowing one mismatch in each consensus sequence.
Table 2. Characteristics of the datasets used in the present studies
50 UTR CR 30 UTR
Genome Chip Forebrain HuD
targets
Genome Chip Forebrain HuD
targets
Genome Chip Forebrain HuD
Targets
Number of sequences 12397 11036 8200 421 23679 19029 8688 608 17918 16359 8363 572
Length 380 367 274 359 1469 1605 1739 1593 1121 1142 1325 1,909
A 20.48 19.92 17.97 18.3 25.52 25.5 25.97 27.63 26.6 26.45 26.39 27.86
U 20.12 19.7 17.93 18.85 22.8 21.95 21.66 22.68 28.76 28.74 29.28 32.95
C 29.23 29.67 30.77 30.9 25.73 25.97 25.52 23.92 22.55 22.65 22.27 19.11
G 30.18 30.71 33.34 31.95 25.95 26.58 26.85 25.77 22.08 22.16 22.06 20.08
30 UTR sequences were retrieved from Ensembl BioMart and datasets were made non-redundant by Gene ID. The datasets were analyzed by scripts
written in Perl v5.8.8 and using BioPerl modules.
Nucleic AcidsResearch, 2010, Vol.38,No. 1 125HuD were unexpected such as regulation of translation
initiation, RNA processing, and protein amino acid
dephosphorylation. Likewise, we found that molecular
categories such as RNA-binding, protein phosphatase
activity type 1 activity, GTP-binding and actin-binding
were signiﬁcantly enriched in HuD targets. Analysis
of cellular components revealed that lamellipodium,
actin cytoskeleton and ribonucleoprotein complex, all
components related to growth cone activity and axonal
growth as well as neural plasticity, were signiﬁcantly
overpopulated with HuD targets. Finally, to put the set
of HuD targets in a biological context we searched for
canonical cellular pathways containing multiple targets.
Among these, we found that the developmental wnt sig-
naling pathway and the long-term potentiation pathway
contain a number of HuD targets (Supplementary
Figure S2). Likewise, analysis of cellular networks using
Metacore software revealed that several networks such as
those centered on b-actin and the translation factor eIF4E
(Supplementary Figure 3) were overpopulated by HuD
targets. These examples highlight the importance of
HuD in the post-transcriptional control of gene regulation
during neural development and synaptic plasticity.
DISCUSSION
The identiﬁcation of the host of cellular targets regulated
by speciﬁc RBPs is critical for understanding the biologi-
cal function of these regulatory proteins. In this study,
we used a two-step mRNA–RBP complex puriﬁcation
method and genome-wide bioinformatics analyses to
identify the targets of the ELAV-like protein HuD,
deﬁne its recognition motifs and characterize the cellular
pathways regulated by this protein. HuD is expressed in
neurons where it promotes axonal growth during nervous
system development and participates in synaptic plasticity
mechanisms in the mature brain (15,17,20,21,50–53).
Not only is HuD present in neuronal cell bodies (14,18),
but it is also localized to growth cones (54) and dendrites
(51), two regions whereby neurons communicate with
each other and the environment and sites of local post-
transcriptional regulation (55,56). Consistent with the
known functions of HuD, we found that its target
mRNAs encoded proteins involved in processes critical
for neuronal diﬀerentiation such as axon guidance, actin
reorganization and wnt signaling. In addition, HuD
targets were found to participate in novel pathways such
as protein phosphatase regulation, ubiquitin ligation and
mRNA transport, processing and translation.
The methods used to isolate mRNAs bound to RNA-
BPs typically utilize either immunoprecipitation of
RNA–protein complexes, with or without prior cross-
linking, or in vitro pull down assays of puriﬁed RNA
with recombinant RNA-BPs. The problem with the
latter method is that it does not take into consideration
that mRNAs that interact in vitro with speciﬁc RNA-BPs
may never do so in vivo as they could be localized to dif-
ferent subcellular fractions or diﬀerent cell types in the
tissue. To avoid this problem, Keene and colleagues
devised a method to isolate mRNP complexes under
conditions that preserve in vivo RNA-protein interactions
(25,26). Given that HuD is known to interact with other
RBPs including other members of the Hu protein family
(30–32), it is possible that some of the mRNAs in the
initial IP could be bound to other protein in the mRNP.
Therefore, to isolate directly bound mRNAs, transcripts
in the HuD IP were further puriﬁed using in vitro pull
downs with recombinant protein and HuD targets were
deﬁned as the mRNAs with highest enrichment values. On
average, HuD targets were found to contain longer 30
UTRs comprising an increased proportion of ARE
sequences and HuD-binding motifs. These motifs were
also signiﬁcantly enriched in a dataset of mRNAs
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Figure 4. Binding aﬃnities of recombinant HuD for the three motifs.
Panels show binding curves of motif 1 (A), motif 2 (B) and motif 3 (C).
In vitro binding assays were performed with increasing amounts of
radiolabeled oligoribonucleotides corresponding to the most likely
sequence in each motif (CCCUCCCUCUCUC for motif 1, UUUUG
UUUUGUUU for motif 2 and UUUUUUUUUUAAA for motif 3)
and ﬁxed amounts GST-HuD as indicated in ‘Materials and Methods’
section. Non-speciﬁc binding was measured using a 100 molar excess
of cold oligoribonucleotides. Binding curves of total (solid line) and
non-speciﬁc (dashed lines) used to calculate the Kd for each motifs.
126 Nucleic Acids Research, 2010,Vol. 38,No. 1upregulated in the forebrain of HuD overexpressor mice,
validating the biological signiﬁcance of these sequences.
All four ELAV-like Hu proteins have been shown to
interact with ARE sequences via their ﬁrst and second
RRMs, while the third RRM binds to long poly A tails
(57,58). Previous predictions of Hu protein binding motifs
have been based upon the consensus sequences of target
mRNAs (27,59). In addition to this criterion, in this study,
we took advantage of the known crystal structure of the
complex of HuD’s RRM I and II and Type I AREs and
restricted our search to motifs that matched its seven
nucleotide (YUNNYUY) minimal consensus sequence
(34). Based on this sequence restriction and the 30 UTR
sequences of the most enriched targets, three new HuD
recognition motifs were identiﬁed. Consistent with the
ARE-binding motifs of other ELAV-like proteins
(27,59), two of the HuD-binding motifs (motifs 2 and 3)
are U-rich; with motif 2 having interspersed Gs similar to
the sex-lethal binding site (47) and the recently identiﬁed
GRE (9) and motif 3 matching class I and II ARE
sequences. HuD was found to bind with high aﬃnity to
ribo-oligonucleotides containing motifs 2 and 3 sequences.
In contrast, binding to motif 1, which is C-rich with
interspersed Us, was about one order of magnitude
lower than that of motif 3. Although none of the
ELAV-binding proteins were shown to recognize pure C
sequences, HuR was found to interact with a CU-rich
element in the androgen receptor mRNA (46).
Analysis of the distribution of all three HuD-binding
motifs in target mRNAs showed that these sequences
were primarily localized to the 30 UTR. Interestingly,
these motifs were also present at higher frequencies in
the 50 UTRs of target mRNAs. Although the vast
majority of instability conferring sequences described so
far mapped to the 30 UTR, a few of them were found in
the 50 UTR and coding region (10,11). Furthermore, for at
least one mRNA, that encoding the cdk inhibitor p27,
HuD binds to an IRES like sequence in its 50 UTR
repressing translation (48). As shown in Table 3, we
found several putative HuD-binding motifs in both the
50 UTR and 30 UTRs of p27 mRNA. In addition to
HuD, HuB was shown to increase translation of
neuroﬁlament M (60) and HuR to block translation of
IGF-I receptor (61). Finally, not only is HuD co-localized
with ribosomes in neuronal cell bodies (18), growth cones
(54) and dendrites (51) but it also, as shown by a recent
study, co-localizes with two important translational
regulators, the poly(A)-binding protein (PABP) and the
cap-binding protein (eIF4E) (62). Altogether, these
results suggest that in addition to controlling mRNA sta-
bility, in some instances HuD and other Hu proteins could
also regulate the rate of translation of speciﬁc mRNAs by
interacting with sequences in the 50 UTR.
Gene ontology and biological pathway analyses
of putative HuD targets revealed several interesting
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Figure 5. Increased frequency of HuD-binding motifs in mRNAs
upregulated in the brains of HuD overexpressor mice. (A) Frequency
of HuD-binding motif 1 in the 50 UTR, CR and 30 UTR of mouse
genome (white bars), Aﬀymetrix 430 2.0 chip genes (light grey bars),
forebrain transcripts (dark grey bars) and mRNAs upregulated
in HuD-Tg mice (black bars). (B) Same analysis for HuD-binding
motif 2. (C) Frequency of motif 3 in the same gene datasets.
***P<0.0001 HuD-Tg mice versus each of the three reference sets
(genome, chip and forebrain), (a) P<0.02 versus genome and chip,
(b) P<0.05 versus genome and chip and (c) P<0.05 versus all three
reference sets.
Nucleic AcidsResearch, 2010, Vol.38,No. 1 127features of this dataset. For instance,  7% of HuD targets
were other RBPs, including HuD itself, HuB, HuR,
polypyrimidine tract binding protein 2 (Ptbp2), CUG
triplet repeat-binding protein 2 (Cugbp2), cytoplasmic
polyadenylation element binding protein 3 (Cpeb3),
poly(rC) binding protein 2 (Pcbp2), Pumillio 2, Staufen
2, Musashi 2 as well as several hnRNP proteins and
splicing factors. Our ﬁnding that HuD binds its own
mRNA and those of other ELAV-like proteins is similar
to that observed for Drosophila ELAV, which has been
shown to bind and downregulate the expression of its
own mRNA (63). These ﬁndings also correlate with
the decreases in HuB and HuR mRNAs observed in the
brains of our HuD overexpressor mice (14). Likewise,
HuR was shown to associate with its cognate mRNA
and with mRNAs encoding other RBPs (40,64).
Additional clues on the importance of HuD in gene regu-
lation comes from our ﬁndings that HuD targets also
encode proteins controlling translational initiation, RNA
export from the nucleus, mRNA splice site selection and
nucleosome assembly (Figure 6). These observations
support a model in which HuD and other RNA-BPs
form a complex and highly integrated network of post-
transcriptional regulators.
In agreement with the role of HuD in neural develop-
ment and axonal outgrowth (24,53,65–68), gene ontology
analyses also revealed that multiple HuD targets are
associated with axon guidance and related processes
such as regulation of actin dynamics and vesicle traﬃck-
ing. Furthermore, other important developmental
pathways such as those involving wnt, TGF-b and b-
catenin signaling are also overpopulated with HuD
targets. Finally, concurring with the known biological
properties of HuD and other Hu proteins in synaptic plas-
ticity (20,21) many HuD targets encode proteins
implicated in these processes. For instance, HuD targets
include protein phosphatases such as PPP1 and PPP3 (aka
PP2B or calcineurin) and a regulator of PPP3 activity
(FKBP1 a.k.a., FKB12), which are known to participate
in long-term potentiation and long-term depression, two
diﬀerent forms of synaptic plasticity (69). Additionally,
another HuD target, the metabotropic glutamate
receptor 5 (mGluR5), is known to control localized
protein synthesis in dendrites during activity-dependent
synaptic remodeling (70). Along these lines, two recent
studies demonstrated the activity-dependent transport
of HuD to neuronal processes and corresponding
increased binding of HuD to the mRNAs for the plas-
ticity associated proteins homer 1a, GAP-43 and
CaMKinIIa (62,71).
In conclusion, our results demonstrate that the ELAV-
like protein HuD binds to three novel motifs in the 30
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128 Nucleic Acids Research, 2010,Vol. 38,No. 1UTRs of its target mRNAs and that multiple HuD targets
encode proteins involved in post-transcriptional gene reg-
ulation, neuronal diﬀerentiation and synaptic remodeling.
These ﬁndings support a post-transcriptional operon
model in which HuD interacts with multiple mRNAs to
regulate these complex biological processes.
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